Literature DB >> 1737537

Topical capsaicin in painful diabetic neuropathy. Effect on sensory function.

R Tandan1, G A Lewis, G B Badger, T J Fries.   

Abstract

OBJECTIVE: To examine the effect of capsaicin on sensory function in painful diabetic neuropathy. RESEARCH DESIGN AND METHODS: We examined the effects of topical 0.075% capsaicin cream on thermal and vibration thresholds in 22 subjects with painful diabetic neuropathy who participated in a double-blind vehicle-controlled therapeutic trial.
RESULTS: After 8 wk of use, there was no significant change in warm and vibration thresholds, but the cold threshold was significantly reduced by capsaicin and vehicle creams to an equal degree. In fewer subjects who used capsaicin cream in an open-label study, there was no significant effect on sensory thresholds after up to 32 wk of use.
CONCLUSIONS: Although our results and those of others show no adverse effects of topical 0.075% capsaicin on human sensory function, even in subjects with preexisting neuropathic sensory impairment, the small number of subjects tested does not justify an inferential statement on safety. Further studies in more subjects are warranted to ensure the long-term safety of capsaicin for pain relief in humans.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1737537     DOI: 10.2337/diacare.15.1.15

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  8 in total

1.  Pharmacological treatment of diabetic peripheral neuropathy.

Authors:  Kenneth Cohen; Nataliya Shinkazh; Jerry Frank; Igor Israel; Chris Fellner
Journal:  P T       Date:  2015-06

Review 2.  Newer agents for the treatment of painful diabetic peripheral neuropathy.

Authors:  Roy Freeman
Journal:  Curr Diab Rep       Date:  2005-12       Impact factor: 4.810

Review 3.  [Ins and outs of neurologic therapy for chronic pain].

Authors:  S Sternberg; F Birklein; A May
Journal:  Nervenarzt       Date:  2008-10       Impact factor: 1.214

Review 4.  New and developing drugs for the treatment of neuropathic pain in diabetes.

Authors:  Roy Freeman
Journal:  Curr Diab Rep       Date:  2013-08       Impact factor: 4.810

5.  Endothelin-1 induces vasodilation in human skin by nociceptor fibres and release of nitric oxide.

Authors:  R R Wenzel; S Zbinden; G Noll; B Meier; T F Lüscher
Journal:  Br J Clin Pharmacol       Date:  1998-05       Impact factor: 4.335

Review 6.  Management of painful diabetic neuropathy.

Authors:  P G Jensen; J R Larson
Journal:  Drugs Aging       Date:  2001       Impact factor: 4.271

Review 7.  Current Pharmacological Treatment of Painful Diabetic Neuropathy: A Narrative Review.

Authors:  Valeriu Ardeleanu; Alexandra Toma; Kalliopi Pafili; Nikolaos Papanas; Ion Motofei; Camelia Cristina Diaconu; Manfredi Rizzo; Anca Pantea Stoian
Journal:  Medicina (Kaunas)       Date:  2020-01-09       Impact factor: 2.430

Review 8.  New treatments for diabetic neuropathy: symptomatic treatments.

Authors:  Singhan T M Krishnan; Gerry Rayman
Journal:  Curr Diab Rep       Date:  2003-12       Impact factor: 5.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.